What is the appropriate workup for spontaneous bacterial peritonitis (SBP) in a cirrhotic patient with ascites?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

SBP Workup in Cirrhotic Patients with Ascites

All cirrhotic patients with ascites admitted to the hospital must undergo immediate diagnostic paracentesis without delay to rule out SBP, even if asymptomatic. 1, 2

When to Perform Diagnostic Paracentesis

Mandatory Situations:

  • Every hospital admission with ascites, regardless of symptoms 1
  • Any clinical deterioration including:
    • Fever or hypothermia
    • Abdominal pain or tenderness
    • Hepatic encephalopathy (new or worsening)
    • Renal dysfunction or rising creatinine
    • GI bleeding
    • Shock or hemodynamic instability
    • Unexplained acidosis or peripheral leukocytosis 1, 2

Critical Procedural Detail:

Do not delay paracentesis for coagulopathy correction. Despite prolonged PT/INR in cirrhotic patients, paracentesis is safe and should proceed. Only consider platelet transfusion if platelets <40,000-50,000/μL 3

Essential Ascitic Fluid Analysis

Immediate Tests (Send on Every Tap):

  1. Cell count with differential - This is your diagnostic cornerstone

    • PMN count >250 cells/mm³ = SBP diagnosis 1, 2
    • Can use manual microscopy or automated flow cytometry 1
  2. Bedside inoculation into blood culture bottles (aerobic and anaerobic)

    • Inoculate at the bedside with at least 10 mL of fluid
    • Increases culture sensitivity to >90% 2
    • Perform before starting antibiotics 1, 2
  3. Total protein concentration 1

  4. Serum-ascites albumin gradient (SAAG) - requires simultaneous serum albumin 1

Additional Tests When PMN >250/mm³:

When SBP is diagnosed, immediately add these tests to distinguish primary from secondary peritonitis 4:

  • Glucose (SBP typically ≥50 mg/dL; <50 suggests perforation)
  • LDH (SBP typically normal; elevated >upper limit of serum suggests perforation)
  • Gram stain (multiple organisms suggest secondary peritonitis)

Red flags for secondary peritonitis (requiring surgical evaluation): 4

  • Total protein >1 g/dL
  • LDH > upper limit of normal for serum
  • Glucose <50 mg/dL
  • Multiple organisms on culture or Gram stain

If these criteria are met, obtain emergent imaging (CT scan, upright/lateral decubitus films) and surgical consultation.

Follow-Up Paracentesis

Repeat tap at 48 hours is NOT routine but should be performed when: 1

  • Inadequate clinical response to antibiotics
  • Suspicion of secondary peritonitis
  • Atypical presentation or organisms

In typical SBP with good clinical response, repeat paracentesis is unnecessary 4. The 48-hour PMN count should decrease with appropriate antibiotics in true SBP; rising PMN despite treatment indicates secondary peritonitis requiring surgical intervention 4.

Simultaneous Blood Cultures

Obtain peripheral blood cultures simultaneously with paracentesis to increase organism isolation rates 2

Common Pitfalls to Avoid

  1. Delaying paracentesis for INR correction - This is dangerous and unnecessary
  2. Waiting for symptoms - Up to 30% of SBP patients are asymptomatic 5
  3. Not inoculating culture bottles at bedside - Delays and transport to lab decrease yield
  4. Starting antibiotics before obtaining fluid - Always tap first when possible
  5. Assuming low-grade symptoms are "just cirrhosis" - Subtle encephalopathy or mild renal dysfunction may be the only SBP manifestation

Antibiotic Initiation

Start empiric antibiotics immediately when PMN >250/mm³, before culture results return. The 2021 British guidelines emphasize tailoring to local resistance patterns, with cefotaxime as the traditional choice but acknowledging rising multidrug-resistant organisms 1. The 2021 AASLD guidance recommends third-generation cephalosporins (cefotaxime 2g IV q12h or ceftriaxone) for community-acquired SBP, but broader coverage (carbapenems) for nosocomial or critically ill patients 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.